Gene search

Sequence information

Select Gene Cds Cds_length GC_content Pep Pep_length
Bva02g01393 ATGAGACCTCAAAGTCTCCATTTTTTCCCAAACCCATATCTCATTTTCTTGCTCAGTATAATTCAAATGAAGCTCTGTTTTTCTGAAATGCTTGTTTTGCCACTCAAAACGCAGCTGATTCCTTCTGGGTTCCTCCCAAGACCACCGAATAAGCTTCGTTTCCACCACAATGTGAGCCTCACGGTTTCTCTTACGGTGGGCACGCCTCCACAGAATGTTTCTATGGTGATTGACACAGGAAGTGAGCTTTCATGGCTGTATTGTAACAGAACCCATAACGTTTCCTCCTCGTTTGACCCGAACCGTTCTTCATCTTACTCGCCCATTTCGTGTTCCTCACCCACCTGTACGAACCAGACCCGGGACTTCCCCATACCCGCTTCCTGTGACTCAAACAACCTCTGCCATGCCACTCTCTCATACGCTGACTTCTCCTCCACCGAAGGTAACCTCGCTTCCGATAGTTTCCGGTTCGGGGGTCCTGATAACCCGGGACTTGTATTCGGGTGCATGAATGCAAGCTCTAGTAGCAGTAGCACTAGCACCGATGCTGACTCCAACAGCACCGGGTTAATGGGTATGAACCGGGGCACCCTCTCCTTTGTTTCTCAAATGAATTTTTCCAAATTCTCTTATTGCATCTCGGGTTCCGATTTCTCGGGGGTTCTACTACTCGGCGACGCCAATTTACCGTGGCTCGCCCCTTTGAATTACACGCCACTGGTTCAAATCTCTACGCCGCTGCCGTATTTTGACCGAGCCGCTTACACGGTTCCACTCCAAGGAATCAAGGTATCGGGTAAGTTGCTCCAAATACCCGAATTCGTTTTTGTTCCCGATCACACAGGGGCGGGTCAGACAATGGTCGATTCAGGGACTCAATTTACCTTTCTCATGGGCCCGGCTTACACTGCATTGAGGGAGGAGTTCTTGAACCAAACAAACACAACTTTGCGGGTCCTCGATGACCCGAATTTCTCTTTCCAAATAGCCATGGATCTCTGCTACCGGATCCCCACGAACCAATCCAGATTTCCCGATTTACCACCCGTGAGCTTGGTTTTCCAAGGGGCGGAAATGAATGTATCCGGTGACGGGCTTTTATACCGGGTGCCGGGCCAGGTGAGGGGGAATGATTCGGTGTGGTGCTTCACCTTTGGGAATTCTGATCTTCTGGGCGTAGAAGCGTTTATCATCGGTCATCACCAGCAGCAGAATATGTGGATGGAATTTGATCTTGTGGAATCTAGAATCGGATTGGCCCAGGTACGTTGTGATTTGGTGGGCCAGAGGCTTGGTTTGGGTTACAACTG 1313 0.4981 MRPQSLHFFPNPYLIFLLSIIQMKLCFSEMLVLPLKTQLIPSGFLPRPPNKLRFHHNVSLTVSLTVGTPPQNVSMVIDTGSELSWLYCNRTHNVSSSFDPNRSSSYSPISCSSPTCTNQTRDFPIPASCDSNNLCHATLSYADFSSTEGNLASDSFRFGGPDNPGLVFGCMNASSSSSSTSTDADSNSTGLMGMNRGTLSFVSQMNFSKFSYCISGSDFSGVLLLGDANLPWLAPLNYTPLVQISTPLPYFDRAAYTVPLQGIKVSGKLLQIPEFVFVPDHTGAGQTMVDSGTQFTFLMGPAYTALREEFLNQTNTTLRVLDDPNFSFQIAMDLCYRIPTNQSRFPDLPPVSLVFQGAEMNVSGDGLLYRVPGQVRGNDSVWCFTFGNSDLLGVEAFIIGHHQQQNMWMEFDLVESRIGLAQVRCDLVGQRLGLGYN 437
       

Annotation information

Select Seq ID Length Analysis Description Start End IPR GO
Bva02g01393 437 Pfam Xylanase inhibitor N-terminal 62 227 IPR032861 -
Bva02g01393 437 Gene3D Acid Proteases 55 226 IPR021109 -
Bva02g01393 437 PANTHER ASPARTYL PROTEASE-RELATED 25 434 IPR001461 GO:0004190|GO:0006508
Bva02g01393 437 ProSiteProfiles Peptidase family A1 domain profile. 60 421 IPR033121 -
Bva02g01393 437 ProSitePatterns Eukaryotic and viral aspartyl proteases active site. 75 86 IPR001969 GO:0004190|GO:0006508
Bva02g01393 437 PANTHER ASPARTIC PROTEINASE PCS1 25 434 - -
Bva02g01393 437 SUPERFAMILY Acid proteases 61 426 IPR021109 -
Bva02g01393 437 CDD pepsin_A_like_plant 61 425 IPR034161 -
Bva02g01393 437 Pfam Xylanase inhibitor C-terminal 255 420 IPR032799 -
Bva02g01393 437 Gene3D Acid Proteases 233 428 IPR021109 -
       

Duplication type information

Select Gene Chromosome Start End Duplicated_type
Bva02g01393 Bva-Chr2 17502227 17504026 Wgd
       

Functional genes information

Select Gene Gene_start Gene_end Function Ath_gene Identity(%) E-value Score
Bva02g01393 62 426 Miscellaneous Gene Families AT1G77480 23.393 1.26e-13 70.5
       

Pathway information

Select Query KO Definition Second KO KEGG Genes ID GHOSTX Score
Bva02g01393 - - qlo:115952190 644.81
       

Event-related genes

Select Gene_1 Chr_1 Start_1 End_1 Gene_2 Chr_2 Start_2 End_2 Event_name
Bva02g01393 02 17502227 17504026 Bva02g01393 02 17502227 17504026 ECH
Bva02g01393 02 17502227 17504026 Bva09g00114 09 529398 531599 ECH
Bva02g01393 02 17502227 17504026 Bva07g02532 07 20196948 20198542 ECH